BOSTON – (July 14, 2014) – Edward Horton, M.D., Senior Investigator at Joslin Diabetes Center and Professor of Medicine at Harvard Medical School, received the Master of the American College of Endocrinology (MACE) Award at the American Association of Clinical Endocrinologists (AACE) 23rd Annual Scientific & Clinical Congress in Las Vegas this past May. 

The MACE Award is given to an AACE member who has obtained the Fellow of the American College of Endocrinology (FACE) distinction, is recognized as a distinguished practicing endocrinologist, serves as a role model for developing endocrinologists, and is a contributor to AACE and to the art and science of endocrinology.

“Only about 40 such awards have been given since they were established in the 1990s, so it is a special honor to receive one of them at this stage of my career,” said Dr. Horton. “I feel doubly honored to have received both the MACE award from ACE and the Albert Renold award from the ADA this year, both of which are tributes to my contributions to research, teaching and training of younger physicians and scientists over the years.”

Dr. Horton is a renowned investigator of obesity and insulin resistance as they relate to diabetes and cardiovascular disease, the regulation of glucose transport and metabolism in skeletal muscle and adipose tissue, and the effects of exercise and physical training on insulin sensitivity.

In addition to serving as a Senior Investigator, Dr. Horton is the Principal Investigator or Co-Investigator for several large National Institutes of Health (NIH) funded studies, such as the Diabetes Prevention Program, the LookAHEAD Study and a Study of Diabetes, Cardiac Disease and Air Pollution Vulnerability.

“I am very fortunate to have had so many outstanding people to work with, both during my time at the University of Vermont and here at Joslin,” said Dr. Horton. “One can’t ask for anything more.”

###

Related Articles

A Scientist working in lab
Type 1
Kidney Disease
Research Highlights

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

Three-year clinical trial finds reducing uric acid levels in type 1 diabetes provides no beneficial impact on the progression of diabetic kidney disease BOSTON – (November 8, 2019) – Diabetic kidney...
Read more on The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion
National Diabetes Month
Type 1
Type 2

National Diabetes Awareness Month

National Diabetes Awareness Month

Diabetes is growing at an epidemic rate in the United States and across the globe. According to the Centers for Disease Control and Prevention (CDC), over 30 million Americans have diabetes and 1.5...
Read more on National Diabetes Awareness Month
Red blood cell traveling in an artery
Type 1
Heart Disease
Research Highlights

Research may show way to minimize complications after heart treatment

Research may show way to minimize complications after heart treatment

BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart disease than those without the condition. They also are several times more likely to develop complications after...
Read more on Research may show way to minimize complications after heart treatment